Ocular Therapeutix's eye-drop replacing punctum plug looks promising at 2 months
Ocular Therapeutix affirms 2-month safety and effectiveness for its drug-eluting intracanalicular plug in treatment of glaucoma and ocular hypertension.
Ocular Therapeutix touted 2-month clinical results for its glaucoma and ocular hypertension treating eye plug, a sustained-release drug-eluting punctum plug.
In a 20-patient clinical trial conducted in South Africa, researchers reported reduced intraocular pressure at 2 months with no excessive tearing or unanticipated adverse events, according to a press release. Findings were similar to treatment with topical brand name ophthalmic solutions, Ocular noted.